
Please try another search
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
Name | Age | Since | Title |
---|---|---|---|
Nurit Benjamini | 55 | 2010 | Independent External Director |
Sandra Panem | 74 | 2014 | Director |
Barbar-Jean Anne Bormann-Kennedy | 62 | 2013 | Director |
Raphael Hofstein | 72 | 2003 | Director |
J. Aaron Ciechanover | 74 | - | Member of Oncology Scientific Advisory Board |
Yosef Yarden | - | 2015 | Member of Oncology Scientific Advisory Board |
Aharon Schwartz | 78 | 2004 | Chairman of the Board |
Michael J. Anghel | 82 | 2010 | Director |
Debasish Francois Roychowdhury | 60 | 2015 | Member of Oncology Scientific Advisory Board |
Jorge Eduardo Cortes | - | 2015 | Member of Oncology Scientific Advisory Board |
Avraham Molcho | 63 | 2010 | Independent External Director |
Ronald Levy | - | 2021 | Member of Immuno-Oncology Scientific Advisory Board |
Ignacio Melero | - | 2021 | Member of Immuno-Oncology Scientific Advisory Board |
Aurelien Marabelle | - | 2021 | Member of Immuno-Oncology Scientific Advisory Board |
Jon Marc Wigginton | 59 | 2021 | Member of Immuno-Oncology Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review